NRIX - Nurix Therapeutics, Inc.
9.645
-1.295 -13.427%
Share volume: 678,455
Last Updated: 05-06-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$10.94
-1.30
-0.12%
View ratios
| Fiscal Date | 05-31-2023 | 08-31-2023 | 11-30-2023 | 02-29-2024 | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | |
| Report Date | 07-13-2023 | 10-12-2023 | 01-28-2025 | 04-10-2024 | 07-11-2024 | 10-11-2024 | 01-28-2025 | 04-08-2025 | |
| Total revenue | 30.676 M | 18.467 M | 15.159 M | 16.585 M | 12.092 M | 12.588 M | 13.284 M | 18.453 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 30.676 M | 18.467 M | 15.159 M | 16.585 M | 12.092 M | 12.588 M | 13.284 M | 18.453 M | |
| -39.80% | -17.91% | 9.41% | -27.09% | 4.10% | 5.53% | 38.91% | |||
| Operating expenses | 57.441 M | 58.479 M | 60.493 M | 61.804 M | 60.632 M | 67.199 M | 77.941 M | 81.317 M | |
| Selling general and admin | 11.678 M | 10.623 M | 10.780 M | 11.799 M | 11.710 M | 11.718 M | 10.717 M | 11.654 M | |
| Research and development | 45.763 M | 47.856 M | 49.713 M | 50.005 M | 48.922 M | 55.481 M | 67.224 M | 69.663 M | |
| Total expenses | 57.441 M | 58.479 M | 60.493 M | 61.804 M | 60.632 M | 67.199 M | 77.941 M | 81.317 M | |
| 1.81% | 3.44% | 2.17% | -1.90% | 10.83% | 15.99% | 4.33% | |||
| Operating income | -26.765 M | -40.012 M | -45.334 M | -45.219 M | -48.540 M | -54.611 M | -64.657 M | -62.864 M | |
| Ebit | -26.765 M | -40.012 M | -45.334 M | -45.219 M | -48.540 M | -54.611 M | -64.657 M | -62.864 M | |
| Pretax income | -24.277 M | -36.982 M | -41.956 M | -41.428 M | -44.456 M | -48.874 M | -58.541 M | -56.351 M | |
| 52.33% | 13.45% | -1.26% | 7.31% | 9.94% | 19.78% | -3.74% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 90.000 K | 90.000 K | 82.000 K | 8.000 K | 0.000 | |
| Net income basic | -24.277 M | -36.982 M | 0.000 | -41.518 M | -44.546 M | 0.000 | 0.000 | 0.000 | |
| -52.33% | 100.00% | -7.29% | 100.00% | ||||||
| Net income | -24.277 M | -36.982 M | -41.956 M | -41.518 M | -44.546 M | -48.956 M | -58.549 M | -56.351 M | |
| -52.33% | -13.45% | 1.04% | -7.29% | -9.90% | -19.60% | 3.75% |
